[1]
“Comparative Evaluation of Antibacterial Efficacy of Commercially Available Rhamnosus Derived Therapeutic Agent Against Cariogenic Microorganism”, AJP, vol. 19, no. 3, Sep. 2025, doi: 10.22377/ajp.v19i3.6750.